The study will include the following study visits & phases:~Visit 1 Screening~Run-in (Baseline) Period - Daily migraine headache diary.~Visit 2 Enrollment -Study enrollment, device and regimen training.~Treatment Period- Relivion® migraine preventive treatment for 12 consecutive weeks. Patients will be required to fill in a daily migraine diary.~Visit 3 Follow Up Visit.~Visit 4 Follow Up Visit.~Visit 5 End of study.~After completion of visit 5 the subject's participation will be over.
The PERL Study will evaluate the safety and efficacy of a self-administered preventive treatment for migraine headache using combined occipital and trigeminal nerve stimulation (Relivion®).~This is a prospective, non-randomized, single arm, multi-center study designed to evaluate the use of Relivion® in reducing the frequency of headache days against a sham performance goal.